Head-to-head comparison
Embody vs yourEra
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Embody offers compounded semaglutide and tirzepatide via injection plus a unique compounded oral tirzepatide gum formulation.
$79/mo (promo rate) sema · $129/mo (promo rate) tirz · Verified July 2026
Marked down on: The $79 flat rate relies on an auto-applied promo 'locked forever' — list price in the terms is $199/mo and reviewers allege the lock isn't honored
Desk Score
A compounded desk that advertises low floors — semaglutide from $79/mo, tirzepatide from $159/mo — with the plan price behind its intake, plus a NAD+ and microdosing menu, across all 50 states.
From $79/mo sema · From $159/mo tirz · Verified August 2026
Marked down on: Compounded only — not FDA-approved and not equivalent to brand Wegovy/Ozempic or Zepbound; availability can tighten as brand shortages resolve
yourEra takes this head-to-head with the higher Desk Score, 85/100 (B) against 83/100 (B) for Embody. Embody still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Embody
83/100
B
yourEra
85/100
B
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Embody | yourEra |
|---|---|---|
| Semaglutide | $79/mopromo rate$79/mo (all doses, promotional rate, compounded) | From $79/moFrom $79/mo (a floor — yourera.com attaches no term, dose or billing cycle to it; the plan price is shown only after the intake quiz; compounded) |
| Tirzepatide | $129/mopromo rate$129/mo (all doses, promotional rate, compounded) | From $159/moFrom $159/mo (a floor — yourera.com attaches no term, dose or billing cycle to it; the plan price is shown only after the intake quiz; compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Yes | Injectable only |
| Best for | Low flat-rate compounded GLP-1 pricing at every dose. | Patients drawn by a low advertised floor on both semaglutide and tirzepatide who are willing to complete the intake to learn the plan price, value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes. |
| Desk Score | 83/100B | 85/100B |
The verdict
Desk pick — yourErayourEra takes this head-to-head with the higher Desk Score, 85/100 (B) against 83/100 (B) for Embody. Embody still holds its ground where its strengths line up with yours.
Choose Embody if…
Low flat-rate compounded GLP-1 pricing at every dose.
$79/mo (promo rate) sema · $129/mo (promo rate) tirz · All 50 states
Choose yourEra if…
Patients drawn by a low advertised floor on both semaglutide and tirzepatide who are willing to complete the intake to learn the plan price, value an add-on NAD+ or microdosing line, and don't need brand-name or oral routes.
From $79/mo sema · From $159/mo tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Embody · yourEra.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Embody
- CoreAge Rx vs yourEra
- Embody vs Strut Health
- Sunlight vs yourEra
- Embody vs Telos Rx
- Lean Meds vs yourEra
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.